|
2024
|
Invention
|
Mirna-485 inhibitors. The present disclosure includes the use of a miR-485 inhibitor for treating... |
|
|
Invention
|
Mirna-485 inhibitors. The present disclosure includes a miR-485 inhibitor for treating a disease ... |
|
|
Invention
|
Microtubule-associated protein tau targeting sirnas and uses thereof. The present disclosure rela... |
|
|
Invention
|
Mirna-484 inhibitors and uses thereof. The present disclosure includes the use of a miR-484 inhib... |
|
|
Invention
|
Sirna targeting alpha-synuclein and uses thereof. The present disclosure relates to siRNA, which ... |
|
2023
|
Invention
|
Treating mitochondrial dysfunction with mirna-485 inhibitor. The present disclosure relates to th... |
|
|
Invention
|
Oligonucleotides targeting indoleamine 2,3-dioxygenase and uses thereof. The present disclosure r... |
|
|
Invention
|
Micellar nanoparticles and uses thereof. The present disclosure includes cationic carrier units c... |
|
2022
|
Invention
|
Amplification-free methods for measuring mirna. The present disclosure relates to oligonucleotide... |
|
|
Invention
|
Use of mir-485 inhibitors to treat age-associated diseases or conditions. The present disclosure ... |
|
|
Invention
|
Use of mirna-485 inhibitors for treating inflammasome-related diseases or disorders. The present ... |
|
|
Invention
|
Codon-optimized nucleotide sequences encoding a coronavirus spike protein and uses thereof. e.g.e... |
|
|
Invention
|
Polynucleotides capable of enhanced protein expression and uses thereof. e.g.e.g., 5'-UTR and 3'-... |
|
|
Invention
|
Use of mirna-485 inhibitors for treating diseases or disorders associated with abnormal nlrp3 exp... |
|
|
Invention
|
Use of mirna-485 inhibitor to regulate psd95, synaptophysin, and caspase-3 expression. The presen... |
|
2021
|
Invention
|
Use of mirna-485 inhibitors for inducing hair growth. The present disclosure includes the use of ... |
|
|
Invention
|
Mirna-485 inhibitor for huntington's disease. The present disclosure includes the use of a miRNA ... |
|
|
Invention
|
Snp diagnostic methods. The present disclosure provides methods and compositions to identify pati... |
|
|
Invention
|
Diagnostic methods using mir-485-3p expression. The present disclosure relates to the use of miR-... |
|
|
Invention
|
Setd7 epigenetic modulators. The present disclosure provides SETD7 modulators (e.g., polypeptides... |
|
|
Invention
|
Diagnostic methods using pgc-1α expression. The present disclosure relates to the use of PGC-1α e... |
|
|
Invention
|
Diagnostic methods using sirt1 expression. The present disclosure relates to the use of SIRT1 exp... |
|
|
Invention
|
Use of mirna-485 inhibitors for treating amyotrophic lateral sclerosis (als). The present disclos... |
|
|
Invention
|
Use of mirna-485 inhibitors for treating tauopathy. The present disclosure includes the use of a ... |
|
|
Invention
|
Mirna-485 inhibitor for gene upregulation. The present disclosure includes the use of a miRNA inh... |
|
2020
|
Invention
|
Compositions and methods for preparing an alzheimer's disease animal model using microrna. The pr... |
|
|
Invention
|
Use of mir-204 inhibitor to increase nurr1 protein expression. The present disclosure includes us... |
|
2019
|
Invention
|
Uses for prevention or treatment of brain diseases using microrna. The present disclosure r... |
|
|
Invention
|
Method for diagnosis of alzheimer's disease using microrna. The present disclosure relates ... |
|
2018
|
Invention
|
Uses for prevention or treatment of brain diseases using microrna. The present invention relates ... |
|
2017
|
Invention
|
Method for diagnosis of alzheimer's disease using microrna. The present invention relates to meth... |
